ArticleCancer immunology, immunotherapy : CII2024

Combinational zimberelimab plus lenvatinib and chemotherapy for alpha-fetoprotein elevated, advanced gastric cancer patients (AFPGC): a phase 1 dose-escalation study.

Ting Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.